The cytoskeleton in papillomavirus infection

Viruses

Volumn 3, Issue 3, 2011, Pages 260-271

  Bienkowska Haba, Malgorzata ^a   Sapp, Martin ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Actin; Cytoskeleton; Microtubule; Papillomavirus; Virus entry

Indexed keywords

CELL MOTILITY; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CELL TRANSPORT; CHROMOSOME SEGREGATION; CYTOSKELETON; CYTOSOL; ENDOCYTOSIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MINICHROMOSOME; MITOSIS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PATHOPHYSIOLOGY; REVIEW; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME;

ANIMALS; CYTOSKELETAL PROTEINS; CYTOSKELETON; HOST-PATHOGEN INTERACTIONS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

PAPILLOMAVIRIDAE;

EID: 79953086591     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3030260     Document Type: Review

References (74)

1. Doorbar, J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32, S7-S15.
2. Roberts, J.N.; Buck, C.B.; Thompson, C.D.; Kines, R.; Bernardo, M.; Choyke, P.L.; Lowy, D.R.; Schiller, J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13, 857-861.
3. Baker, T.S.; Newcomb, W.W.; Olson, N.H.; Cowsert, L.M.; Olson, C.; Brown, J.C. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 1991, 60, 1445-1456.
4. Buck, C.B.; Cheng, N.; Thompson, C.D.; Lowy, D.R.; Steven, A.C.; Schiller, J.T.; Trus, B.L. Arrangement of L2 within the papillomavirus capsid. J. Virol. 2008, 82, 5190-5197.
5. Finnen, R.L.; Erickson, K.D.; Chen, X.S.; Garcea, R.L. Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 2003, 77, 4818-4826.
6. Liu, W.J.; Gissmann, L.; Sun, X.Y.; Kanjanahaluethai, A.; Muller, M.; Doorbar, J.; Zhou, J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 1997, 227, 474-483.
7. Kondo, K.; Ishii, Y.; Ochi, H.; Matsumoto, T.; Yoshikawa, H.; Kanda, T. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 2007, 358, 266-272.
8. Day, P.M.; Gambhira, R.; Roden, R.B.; Lowy, D.R.; Schiller, J.T. Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies. J. Virol. 2008, 82, 4638-4646.
9. Yang, R.; Day, P.M.; Yutzy, W.H.; Lin, K.Y.; Hung, C.F.; Roden, R.B. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 2003, 77, 3531-3541.
10. Buck, C.B.; Pastrana, D.V.; Lowy, D.R.; Schiller, J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78, 751-757.
11. Kawana, K.; Yoshikawa, H.; Taketani, Y.; Yoshiike, K.; Kanda, T. In vitro construction of pseudovirions of human papillomavirus type 16: Incorporation of plasmid DNA into reassembled L1/L2 capsids. J. Virol. 1998, 72, 10298-10300.
12. Kirnbauer, R.; Booy, F.; Cheng, N.; Lowy, D.R.; Schiller, J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 12180-12184.
13. Müller, M.; Gissmann, L.; Cristiano, R.J.; Sun, X.Y.; Frazer, I.H.; Jenson, A.B.; Alonso, A.; Zentgraf, H.; Zhou, J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 1995, 69, 948-954.
14. Roden, R.B.; Greenstone, H.L.; Kirnbauer, R.; Booy, F.P.; Jessie, J.; Lowy, D.R.; Schiller, J.T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 1996, 70, 5875-5883.
15. Roden, R.B.; Kirnbauer, R.; Jenson, A.B.; Lowy, D.R.; Schiller, J.T. Interaction of papillomaviruses with the cell surface. J. Virol. 1994, 68, 7260-7266.
16. Unckell, F.; Streeck, R.E.; Sapp, M. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 1997, 71, 2934-2939.
17. Volpers, C.; Sapp, M.; Snijders, P.J.; Walboomers, J.M.; Streeck, R.E. Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2. J. Gen. Virol. 1995, 76, 2661-2667.
18. Ozbun, M.A. Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. J. Virol. 2002, 76, 11291-11300.
19. Day, P.M.; Lowy, D.R.; Schiller, J.T. Heparan sulfate-independent cell binding and infection with furin pre-cleaved papillomavirus capsids. J. Virol. 2008, 82, 12565-12568.
20. Giroglou, T.; Florin, L.; Schäfer, F.; Streeck, R.E.; Sapp, M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 2001, 75, 1565-1570.
21. Joyce, J.G.; Tung, J.-S.; Przysiecki, C.T.; Cook, J.C.; Lehman, E.D.; Sands, J.A.; Jansen, K.U.; Keller, P.M. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 1999, 274, 5810-5822.
22. Bernfield, M.; Kokenyesi, R.; Kato, M.; Hinkes, M.T.; Spring, J.; Gallo, R.L.; Lose, E.J. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 1992, 8, 365-393.
23. Fransson, L.A. Glypicans. Int. J. Biochem. Cell Biol. 2003, 35, 125-129.
24. Culp, T.D.; Budgeon, L.R.; Christensen, N.D. Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 2006, 347, 147-159.
25. Culp, T.D.; Budgeon, L.R.; Marinkovich, M.P.; Meneguzzi, G.; Christensen, N.D. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J. Virol. 2006, 80, 8940-8950.
26. Johnson, K.M.; Kines, R.C.; Roberts, J.N.; Lowy, D.R.; Schiller, J.T.; Day, P.M. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 2009, 83, 2067-2074.
27. Selinka, H.C.; Florin, L.; Patel, H.D.; Freitag, K.; Schmidtke, M.; Makarov, V.A.; Sapp, M. Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Non-Infectious Uptake of Human Papillomavirus. J. Virol. 2007, 81, 10970-10980.
28. Knappe, M.; Bodevin, S.; Selinka, H.C.; Spillmann, D.; Streeck, R.E.; Chen, X.S.; Lindahl, U.; Sapp, M. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J. Biol. Chem. 2007, 282, 27913-27922.
29. Selinka, H.C.; Giroglou, T.; Nowak, T.; Christensen, N.D.; Sapp, M. Further evidence that papillomavirus particles exist in two distinct conformations. J. Virol. 2003, 77, 12961-12967.
30. Dasgupta, J.; Bienkowska-Haba, M.; Ortega, M.E.; Patel, H.D.; Bodevin, S.; Spillmann, D.; Bishop, B.; Sapp, M.; Chen, X.S. Structural basis of oligosaccharide receptor recognition by human Papillomavirus. J. Biol. Chem. 2011, 286, 2617-2624.
31. Patterson, N.A.; Smith, J.L.; Ozbun, M.A. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J. Virol. 2005, 79, 6838-6847.
32. Buck, C.B.; Thompson, C.D.; Roberts, J.N.; Muller, M.; Lowy, D.R.; Schiller, J.T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006, 2, e69.
33. Smith, J.L.; Lidke, D.S.; Ozbun, M.A. Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix. Virology 2008, 381, 16-21.
34. Schelhaas, M.; Ewers, H.; Rajamaki, M.L.; Day, P.M.; Schiller, J.T.; Helenius, A. Human papillomavirus type 16 entry: Retrograde cell surface transport along actin-rich protrusions. PLoS Pathog. 2008, 4, e1000148.
35. Kines, R.C.; Thompson, C.D.; Lowy, D.R.; Schiller, J.T.; Day, P.M. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 20458-20463.
36. Roth, S.D.; Sapp, M.; Streeck, R.E.; Selinka, H.C. Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33. Virol. J. 2006, 3, 83.
37. Richards, R.M.; Lowy, D.R.; Schiller, J.T.; Day, P.M. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 1522-1527.
38. Hanoulle, X.; Melchior, A.; Sibille, N.; Parent, B.; Denys, A.; Wieruszeski, J.M.; Horvath, D.; Allain, F.; Lippens, G.; Landrieu, I. Structural and functional characterization of the interaction between cyclophilin B and a heparin-derived oligosaccharide. J. Biol. Chem. 2007, 282, 34148-34158.
39. Vanpouille, C.; Deligny, A.; Delehedde, M.; Denys, A.; Melchior, A.; Lienard, X.; Lyon, M.; Mazurier, J.; Fernig, D.G.; Allain, F. The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. J. Biol. Chem. 2007, 282, 24416-24429.
40. Bienkowska-Haba, M.; Patel, H.D.; Sapp, M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog. 2009, 5, e1000524.
41. Smith, J.L.; Campos, S.K.; Ozbun, M.A. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 2007, 81, 9922-9931.
42. Christensen, N.D.; Cladel, N.M.; Reed, C.A. Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 1995, 207, 136-142.
43. Culp, T.D.; Christensen, N.D. Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 2004, 319, 152-161.
44. Schelhaas, M. Come in and take your coat off-How host cells provide endocytosis for virus entry. Cell Microbiol. 2010, 12, 1378-1388.
45. Spoden, G.; Freitag, K.; Husmann, M.; Boller, K.; Sapp, M.; Lambert, C.; Florin, L. Clathrin- and caveolin-independent entry of human papillomavirus type 16-Involvement of tetraspanin-enriched microdomains (TEMs). PLoS ONE 2008, 3, e3313.
46. Volpers, C.; Unckell, F.; Schirmacher, P.; Streeck, R.E.; Sapp, M. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 1995, 69, 3258-3264.
47. Abban, C.Y.; Bradbury, N.A.; Meneses, P.I. HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am. J. Ther. 2008, 15, 304-311.
48. Day, P.M.; Lowy, D.R.; Schiller, J.T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307, 1-11.
49. Laniosz, V.; Holthusen, K.A.; Meneses, P.I. Bovine papillomavirus type 1: From clathrin to caveolin. J. Virol. 2008, 82, 6288-6298.
50. Bousarghin, L.; Touze, A.; Sizaret, P.Y.; Coursaget, P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 2003, 77, 3846-3850.
51. Hindmarsh, P.L.; Laimins, L.A. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol. J. 2007, 4, 19.
52. Mercer, J.; Schelhaas, M.; Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79, 803-833.
53. Selinka, H.C.; Giroglou, T.; Sapp, M. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 2002, 299, 279-287.
54. Liu, W.J.; Qi, Y.M.; Zhao, K.N.; Liu, Y.H.; Liu, X.S.; Frazer, I.H. Association of bovine papillomavirus type 1 with microtubules. Virology 2001, 282, 237-244.
55. Sapp, M.; Bienkowska-Haba, M. Viral entry mechanisms: Human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J. 2009, 276, 7206-7216.
56. Smith, J.L.; Campos, S.K.; Wandinger-Ness, A.; Ozbun, M.A. Caveolin-1 dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J. Virol. 2008, 82, 9505-9512.
57. Kämper, N.; Day, P.M.; Nowak, T.; Selinka, H.C.; Florin, L.; Bolscher, J.; Hilbig, L.; Schiller, J.T.; Sapp, M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 2006, 80, 759-768.
58. Huang, H.S.; Buck, C.B.; Lambert, P.F. Inhibition of gamma secretase blocks HPV infection. Virology 2010, 407, 391-396.
59. Karanam, B.; Peng, S.; Li, T.; Buck, C.; Day, P.M.; Roden, R.B. Papillomavirus infection requires gamma secretase. J. Virol. 2010, 84, 10661-10670.
60. Florin, L.; Becker, K.A.; Lambert, C.; Nowak, T.; Sapp, C.; Strand, D.; Streeck, R.E.; Sapp, M. Identification of a dynein interacting domain in the papillomavirus minor capsid protein L2. J. Virol. 2006, 80, 6691-6696.
61. Schneider, M.A.; Spoden, G.A.; Florin, L.; Lambert, C. Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol. 2011, 13, 32-46.
62. Pyeon, D.; Pearce, S.M.; Lank, S.M.; Ahlquist, P.; Lambert, P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009, 5, e1000318.
63. Day, P.M.; Baker, C.C.; Lowy, D.R.; Schiller, J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 14252-14257.
64. You, J.; Croyle, J.L.; Nishimura, A.; Ozato, K.; Howley, P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004, 117, 349-360.
65. Sekhar, V.; Reed, S.C.; McBride, A.A. Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes. J. Virol. 2010, 84, 543-557.
66. McBride, A.A. Replication and partitioning of papillomavirus genomes. Adv. Virus Res. 2008, 72, 155-205.
67. Duensing, S.; Lee, L.Y.; Duensing, A.; Basile, J.; Piboonniyom, S.; Gonzalez, S.; Crum, C.P.; Munger, K. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 10002-10007.
68. Duensing, S.; Duensing, A.; Flores, E.R.; Do, A.; Lambert, P.F.; Munger, K. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol. 2001, 75, 7712-7716.
69. Duensing, A.; Spardy, N.; Chatterjee, P.; Zheng, L.; Parry, J.; Cuevas, R.; Korzeniewski, N.; Duensing, S. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environ. Mol. Mutagen. 2009, 50, 741-747.
70. Korzeniewski, N.; Spardy, N.; Duensing, A.; Duensing, S. Genomic instability and cancer: Lessons learned from human papillomaviruses. Cancer Lett. 2010, doi:10.1016/j.canlet.2010.10.013.
71. Moody, C.A.; Laimins, L.A. Human papillomavirus oncoproteins: Pathways to transformation. Nat. Rev. Cancer 2010, 10, 550-560.
72. Ward, B.M. The taking of the cytoskeleton one two three: How viruses utilize the cytoskeleton during egress. Virology 2011, doi:10.1016/j.virol.2010.12.024.
73. McIntosh, P.B.; Laskey, P.; Sullivan, K.; Davy, C.; Wang, Q.; Jackson, D.J.; Griffin, H.M.; Doorbar, J. E1^E4-mediated keratin phosphorylation and ubiquitylation: A mechanism for keratin depletion in HPV16-infected epithelium. J. Cell Sci. 2010, 123, 2810-2822.
74. Wang, Q.; Griffin, H.; Southern, S.; Jackson, D.; Martin, A.; McIntosh, P.; Davy, C.; Masterson, P.J.; Walker, P.A.; Laskey, P.; Omary, M.B.; Doorbar, J. Functional analysis of the human papillomavirus type 16 E1 = E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J. Virol. 2004, 78, 821-833.